期刊文献+

基于专利分析的中国医疗器械子领域的识别研究 被引量:3

Identification of the Key Subfields of Medical Devices Based on Patent Analysis
下载PDF
导出
摘要 医疗器械是一个多学科交叉的高技术行业,本研究采用定量与定性相结合的分析方法识别中国医疗器械的重点子领域。通过对Derwent Innovation数据库中医疗器械领域的专利进行检索,根据国家药品监督管理局组织修订的《医疗器械分类目录》,并结合医药器械的专利分类特点,将医疗器械领域专利分为17个子领域,采用统计学分析方法对中国医疗器械17个子领域技术开发特点进行分析,并对重点子领域进行识别。中国在医疗器械的消毒灭菌设备,注输、护理和防护器械,医院设备,呼吸麻醉和急救器械,患者承载器械五个子领域占据创新优势。 Medical device is a high-tech industry,with the characteristic of multidisciplinary intersection.This study used quantitative and qualitative analysis methods to identify the key subfields of medical devices in China.Through the retrieval of patents in the field of medical devices in the Derwent Innovation database,according to Medical Device Classification organized by National Medical Products Administration,combined with the patent features of medical devices,the patents in the field of medical devices were divided into 17 subfields.Statistical analysis methods were used to analyze the 17 subfields and also identify the key ones of medical devices in China.China has an innovative advantage in the five subfields:such as sterilization equipment,injection,care and protective equipment,hospital equipment,respiratory anesthesia and first aid equipment,and patient carrying devices.
作者 张婷 陈娟 欧阳昭连 池慧 ZHANG Ting;CHEN Juan;OUYANG Zhaolian;CHI Hui(Institute of Medical Information/Medical Library,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100020,China)
出处 《中国医疗设备》 2020年第3期120-124,共5页 China Medical Devices
基金 国家重点研究发展计划项目(2016YFC0104805) 中国医学科学院中央级公益性科研院所基本科研业务费专项(2017PT63006) 中国医学科学院医学与健康科技创新工程课题(2016-I2M-2-004)。
关键词 医疗器械 专利分析 重点子领域识别 medical devices patent analysis identification of the key subfields
  • 相关文献

参考文献15

二级参考文献149

  • 1于德泉.天然产物与创新药物研究开发[J].中国天然药物,2005,3(6):321-321. 被引量:11
  • 2毕毅,徐进宜,吴晓明.抗艾滋病药物的研究进展[J].中国现代应用药学,2005,22(6):461-465. 被引量:6
  • 3谢世平,张淼,李素香,程五中,祝应俊.艾滋病并发症的治疗现状[J].中医研究,2007,20(3):62-62. 被引量:5
  • 4Celia FO, Marta D, Yudith R, et al. Non-induced leukocyte extract reduces HIV replication and TNF secretion[J]. Biochem Biophys Res Comm, 2004, 325(3): 1075-1081.
  • 5Vidal V, Potterat O, Louvel S, et al. Library-based discovery and characterization of daphnane diterpenes as potent and selective HIV inhibitors in Daphne gnidium [J]. Journal of Natural Products, 2012, 75(3): 414-419.
  • 6Duan HQ, Takaishi Y, lmakura Y, et al. Sesquiterpene alkaloids from Tripterygium hypoglaucum and Tripterygium wilfordii: anew class of potent anti-HIV agents [J]. Journal of Natural Products, 2000, 63(3): 357-361.
  • 7Yang SS, Cragg GM, Newman D J, et al. Natural product-based anti-HIV drug discovery and development facilitated by the NCI developmental therapeutics program [J]. Journal of Natural Products, 2001, 64(4): 554-554.
  • 8Singh SB, Ondeyka JG, SchleifWA, et al. Chemistry and structure-activity relationship of HIV-1 integrase inhibitor integracide B and related natural products [J]. Journal of Natural Products,2003, 66(10): 1338-1344.
  • 9Lu ZY, Harper MK, Pond CD, et al. Thiazoline peptides and a tris-phenethyl urea from Didemnum molle with anti-HIV activity[J]. Journal of Natural Products, 2012, 75(8): 1436-1440.
  • 10Plaza A, Garcia R, Bifulco G, et al. Aetheramides A and B, potent HIV-inhibitory depsipeptides from a Myxobacterium of the new genus "Aetherobacter"[J]. Organic Letters, 2012, 14(11): 2854-2857.

共引文献157

同被引文献45

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部